| References |
| 1 |
Cerner Multum, Inc. "Australian Product Information.".
|
| 2 |
Cerner Multum, Inc. "UK Summary of Product Characteristics.".
|
| 3 |
D'Arcy PF, McElnay JC "Drug-antacid interactions: assessment of clinical importance." Drug Intell Clin Pharm 21 (1987): 607-17. [PMID: 2886325]
|
| 4 |
Iwuagwu MA, Aloko KS "Adsorption of paracetamol and chloroquine phosphate by some antacids." J Pharm Pharmacol 44 (1992): 655-8. [PMID: 1359089]
|
| 5 |
McElnay JC, Mukhtar HA, Arcy PF, Temple DJ "In vitro experiments on chloroquine and pyrimethamine absorption in the presence of antacid constituents or kaolin." J Trop Med Hyg 85 (1982): 153-8. [PMID: 7143531]
|
| 6 |
McElnay JC, Mukhtar HA, D'Arcy PF, Temple DJ, Collier PS "The effect of magnesium trisilicate and kaolin on the in vivo absorption of chloroquine." J Trop Med Hyg 85 (1982): 159-63. [PMID: 6292443]
|
| 7 |
Product Information. Aralen (chloroquine). Sanofi Winthrop Pharmaceuticals, New York, NY.
|
| 8 |
Wallace AW, Amsden GW "Is it really OK to take this with food? Old interactions with a new twist." J Clin Pharmacol 42 (2002): 437-43. [PMID: 11936569]
|